Targovax's Series A Round

Targovax raised a round of funding on February 01, 2012.

Targovax is an Oslo-area based global biotechnology company, dedicated to the design and development of immunotherapy vaccines for patients with RAS-mutated cancers.…

Articles about Targovax's Series A Round: